Usefulness of thyrotropin-releasing hormone test, SMS 201–995, and bromocriptine in the diagnosis and treatment of gonadotropin-secreting pituitary adenomas
Authors:
- 1 February 1994
- journal article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 17 (2) , 99-104
Abstract
Five patients with gonadotropin-secreting pituitary adenomas were studied. The utility of gonadotropin response to TRH stimulation in the diagnosis and follow-up of these tumors was evaluated, as well as the effects of somatostatin analogue SMS 201–995 and bromocriptine on gonadotropin release. Three patients had FSH and LH secreting adenomas while the other two tumors secreted FSH and a-subunit. Transsphenoidal resection of the pituitary adenomas were performed in all patients. Following preoperative TRH administration (400 μg iv), marked increases were observed in FSH levels in two cases, in LH levels in three and in α-subunit in one. The FSH and LH responses to this stimulus persisted in the same patients after surgery. Following acute bromocriptine administration (5 mg orally), FSH was reduced in all cases by 19% to 46%; LH in three cases by 50–67% and α-subunit in one by 33%. In patient no. 5, with persistent high FSH levels in the immedi.ate postoperative period, long-term bromocriptine treatment was administered (15 mg/d orally), resulting in normalization of FSH levels 6 months later, although the size of the tumor was not reduced. After acute SMS 201–995 administration (100 μg sc) FSH decreased in two cases by 38% and 76%, LH in three by 30–56% and a-subunit in one by 20%. We conclude that gonadotropin response to TRH stimulation is useful in the diagnosis and follow-up of patients with gonadotroph adenoma. Bromocriptine and SMS 201–995 may be effective as coadjuvant treatment following surgery and radiotherapy in these patients, although long-term studies will be necessary to confirm these proposals.Keywords
This publication has 27 references indexed in Scilit:
- Reduction in size of a thyrotropin- and gonadotropin-secreting pituitary adenoma treated with octreotide acetate (somatostatin analog).The Journal of Clinical Endocrinology & Metabolism, 1992
- Effects of dopamine and somatostatin on pulsatile pituitary glycoprotein secretion.The Journal of Clinical Endocrinology & Metabolism, 1992
- Diagnosis and Management of Hormone-Secreting Pituitary AdenomasNew England Journal of Medicine, 1991
- Gonadotroph-Cell Pituitary AdenomasNew England Journal of Medicine, 1991
- Recognition of Gonadotroph Adenomas in WomenNew England Journal of Medicine, 1991
- LH AND FSH SECRETION AND RESPONSES TO GnRH AND TRH IN PATIENTS WITH CLINICALLY FUNCTIONLESS PITUITARY ADENOMASClinical Endocrinology, 1990
- Hormone production in clinically nonfunctioning pituitary adenomasJournal of Neurosurgery, 1987
- Follicle-Stimulating Hormone-Secreting Pituitary AdenomasThe Journal of Clinical Endocrinology & Metabolism, 1985
- DISCORDANT SERUM α‐SUBUNIT AND FSH CONCENTRATIONS IN A WOMAN WITH A PITUITARY TUMOURClinical Endocrinology, 1984
- Glycoprotein hormone α-subunit secretion in patients with pituitary adenomas: influence of TRH, LRH and bromocriptineEuropean Journal of Endocrinology, 1982